I think the company is good, but if you see its sale has a CAGR of 20% for the last 12-13 years but the problem is the bottom line which hasn’t moved more than 5-6%.
Also, the company doesn’t seem to have the advantage of passing the price hike, which can be seen in its stock price.
Pls answer this question, If we see the difference between FY22 and FY23, there has been a difference of around 127Crs in reserves, did they do any huge CAPEX?
The company has made Mr. V Bharathram as MD, how well he will make the company go big and how he will contribute is the question
His LinkedIn ID – https://www.linkedin.com/in/vbharathram/?originalSubdomain=in
| Subscribe To Our Free Newsletter |
